Vital Living Inc. (VTLV) bei hohen Volumen fester - 500 Beiträge pro Seite
eröffnet am 12.11.02 21:34:32 von
neuester Beitrag 12.11.02 22:05:02 von
neuester Beitrag 12.11.02 22:05:02 von
Beiträge: 2
ID: 659.176
ID: 659.176
Aufrufe heute: 0
Gesamt: 148
Gesamt: 148
Aktive User: 0
Top-Diskussionen
Titel | letzter Beitrag | Aufrufe |
---|---|---|
vor 1 Stunde | 7096 | |
vor 1 Stunde | 7017 | |
heute 21:35 | 4758 | |
heute 21:02 | 3584 | |
vor 1 Stunde | 3481 | |
vor 1 Stunde | 2899 | |
vor 1 Stunde | 2058 | |
heute 15:55 | 1966 |
Meistdiskutierte Wertpapiere
Platz | vorher | Wertpapier | Kurs | Perf. % | Anzahl | ||
---|---|---|---|---|---|---|---|
1. | 1. | 17.749,00 | -0,14 | 174 | |||
2. | 2. | 150,08 | -3,45 | 121 | |||
3. | 4. | 7,0000 | -5,41 | 77 | |||
4. | 3. | 2.378,60 | +0,74 | 57 | |||
5. | 8. | 0,1845 | -8,21 | 56 | |||
6. | Neu! | 6,6100 | +7,48 | 54 | |||
7. | 5. | 6,7290 | +2,08 | 54 | |||
8. | 6. | 3,7400 | +3,82 | 52 |
Interessanter Wert...bitte die Internet Seiten anschauen.
PHOENIX, Aug 27, 2002 (BUSINESS WIRE) -- Vital Living Inc. (VTLV) , the
Physician Nutraceutical Company(SM), today announced it has successfully
initiated sales of its medical food supplement, Essentum(TM), to patients at The
Arizona Heart Institute (AHI) based in Phoenix.
Essentum(TM) provides specific nutritional ingredients for cardiovascular health and
is delivered directly to the consumer as part of a comprehensive cardiovascular
health program.
"Vital Living is excited to introduce evidence-based nutritional intervention to
promote cardiovascular health. We are pleased to join forces with The Arizona
Heart Institute, one of the most innovative heart clinics nationwide, to offer
cardiovascular patients Essentum medical food supplement," stated Brad Edson,
CEO of Vital Living Inc.
"Currently 100 million Americans use nutritional supplements. Unfortunately, most
of this use is self-directed, and physicians and consumers alike have concerns as
to safety and efficacy of these products. Now, with Essentum, consumers can
integrate proven nutrition as part of their treatment protocol under the supervision
and recommendation of their physician."
Essentum is the first medical food supplement developed by Vital Living`s Scientific
Advisory Board of leading cardiologists and cardiovascular specialists.
Essentum contains only clinically proven nutritional ingredients to address the
specific needs of cardiovascular patients in the following areas: increasing HDL
("good") cholesterol while lowering LDL ("bad") cholesterol, total triglycerides, and
homocysteine. Essentum(TM) also provides recommended daily intakes (RDI) of
essential nutrients in highly absorbable forms, and is designed to not counteract
with prescription medications commonly prescribed to cardiovascular patients.
About Vital Living
Vital Living develops and markets evidence-based nutraceuticals formulated by
physicians for distribution through physicians. The company is developing and
testing nutraceuticals in collaboration with leading medical experts based on the
best available scientific evidence.
Vital Living`s nutraceuticals are designed to be incorporated by physicians into a
standard physician/patient program, supported by a specially designed compliance
regimen. The company`s initial area of focus is cardiovascular health, the leading
health concern in America affecting 60 million consumers.
About The Arizona Heart Institute
The Arizona Heart Institute (AHI), based in Phoenix, is a multispecialty outpatient
facility dedicated to the prevention, detection, and treatment of cardiovascular
disorders.
AHI has the distinction of being the nation`s first freestanding outpatient clinic built
solely to combat heart disease and specializes in today`s most advanced
non-surgical interventional therapies that replace traditional scalpel and suture
treatment for heart and blood vessel disease.
AHI`s leadership role in developing new technologies for preventing and treating
cardiovascular disease has carried its reputation far beyond the United States.
Physicians and patients travel from around the world to learn of and receive the
latest treatment techniques.
Except for any historical information, the matters discussed in this press release
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
These forward-looking statements involve risks and uncertainties, including
activities, events or developments that the company expects, believes or
anticipates will or may occur in the future.
A number of factors could cause actual results to differ from those indicated in the
forward-looking statements, including the company`s ability to continue to
successfully market and provide its products and services and maintain their
effectiveness, the continuation of the arrangements with the company`s product
development partners, the ability of the company to meet its financial projections,
and general economic conditions.
Such statements are subject to a number of assumptions, risks and uncertainties.
Readers are cautioned that such statements are not guarantees of future
performance and that actual results or developments may differ materially from
those set forth in the forward-looking statements.
The company undertakes no obligation to publicly update or revise forward-looking
statements, whether as a result of new information or otherwise.
CONTACT: Vital Living Inc., Phoenix
Brad Edson, 602/952-9909
bedson@vitalliving.com
www.vitalliving.com
URL: http://www.businesswire.com
Physician Nutraceutical Company(SM), today announced it has successfully
initiated sales of its medical food supplement, Essentum(TM), to patients at The
Arizona Heart Institute (AHI) based in Phoenix.
Essentum(TM) provides specific nutritional ingredients for cardiovascular health and
is delivered directly to the consumer as part of a comprehensive cardiovascular
health program.
"Vital Living is excited to introduce evidence-based nutritional intervention to
promote cardiovascular health. We are pleased to join forces with The Arizona
Heart Institute, one of the most innovative heart clinics nationwide, to offer
cardiovascular patients Essentum medical food supplement," stated Brad Edson,
CEO of Vital Living Inc.
"Currently 100 million Americans use nutritional supplements. Unfortunately, most
of this use is self-directed, and physicians and consumers alike have concerns as
to safety and efficacy of these products. Now, with Essentum, consumers can
integrate proven nutrition as part of their treatment protocol under the supervision
and recommendation of their physician."
Essentum is the first medical food supplement developed by Vital Living`s Scientific
Advisory Board of leading cardiologists and cardiovascular specialists.
Essentum contains only clinically proven nutritional ingredients to address the
specific needs of cardiovascular patients in the following areas: increasing HDL
("good") cholesterol while lowering LDL ("bad") cholesterol, total triglycerides, and
homocysteine. Essentum(TM) also provides recommended daily intakes (RDI) of
essential nutrients in highly absorbable forms, and is designed to not counteract
with prescription medications commonly prescribed to cardiovascular patients.
About Vital Living
Vital Living develops and markets evidence-based nutraceuticals formulated by
physicians for distribution through physicians. The company is developing and
testing nutraceuticals in collaboration with leading medical experts based on the
best available scientific evidence.
Vital Living`s nutraceuticals are designed to be incorporated by physicians into a
standard physician/patient program, supported by a specially designed compliance
regimen. The company`s initial area of focus is cardiovascular health, the leading
health concern in America affecting 60 million consumers.
About The Arizona Heart Institute
The Arizona Heart Institute (AHI), based in Phoenix, is a multispecialty outpatient
facility dedicated to the prevention, detection, and treatment of cardiovascular
disorders.
AHI has the distinction of being the nation`s first freestanding outpatient clinic built
solely to combat heart disease and specializes in today`s most advanced
non-surgical interventional therapies that replace traditional scalpel and suture
treatment for heart and blood vessel disease.
AHI`s leadership role in developing new technologies for preventing and treating
cardiovascular disease has carried its reputation far beyond the United States.
Physicians and patients travel from around the world to learn of and receive the
latest treatment techniques.
Except for any historical information, the matters discussed in this press release
contain forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934.
These forward-looking statements involve risks and uncertainties, including
activities, events or developments that the company expects, believes or
anticipates will or may occur in the future.
A number of factors could cause actual results to differ from those indicated in the
forward-looking statements, including the company`s ability to continue to
successfully market and provide its products and services and maintain their
effectiveness, the continuation of the arrangements with the company`s product
development partners, the ability of the company to meet its financial projections,
and general economic conditions.
Such statements are subject to a number of assumptions, risks and uncertainties.
Readers are cautioned that such statements are not guarantees of future
performance and that actual results or developments may differ materially from
those set forth in the forward-looking statements.
The company undertakes no obligation to publicly update or revise forward-looking
statements, whether as a result of new information or otherwise.
CONTACT: Vital Living Inc., Phoenix
Brad Edson, 602/952-9909
bedson@vitalliving.com
www.vitalliving.com
URL: http://www.businesswire.com
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
173 | ||
120 | ||
75 | ||
58 | ||
53 | ||
52 | ||
52 | ||
45 | ||
44 | ||
39 |
Wertpapier | Beiträge | |
---|---|---|
39 | ||
30 | ||
30 | ||
29 | ||
28 | ||
28 | ||
24 | ||
23 | ||
20 | ||
19 |